![Utpal Koppikar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Utpal Koppikar
Direttore/Membro del Consiglio presso
C4 THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/05/2026
Profilo
Utpal Koppikar is currently an Independent Director at C4 Therapeutics, Inc. since 2022 and Chief Financial Officer at Verily Life Sciences LLC since 2023.
Formerly, Mr. Koppikar was Chief Financial Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2018 to 2023, Vice President-Corporate & Operations Finance at Gilead Sciences, Inc. from 2017 to 2018, and Director at Flexion Therapeutics, Inc. in 2021.
Education includes graduate studies at Stanford University, an undergraduate degree from the University of Maryland, and an MBA from UCLA Anderson School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Utpal Koppikar
| Società | Posizione | Inizio |
|---|---|---|
| C4 THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 16/03/2022 |
Verily Life Sciences LLC
 Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Direttore Finanziario/CFO | 01/04/2023 |
Precedenti posizioni note di Utpal Koppikar
| Società | Posizione | Fine |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Direttore Finanziario/CFO | 31/03/2023 |
| FLEXION THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 19/11/2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2018 |
Formazione di Utpal Koppikar
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
30
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Verily Life Sciences LLC
Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Technology Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
